A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder

類似資料

• Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder
  著者:: Boulenger, Jean-Philippe, 等
  出版事項: (2014)
• Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant
  著者:: Chen, Grace, 等
  出版事項: (2013)
• Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
  著者:: Alam, Mohammed Y., 等
  出版事項: (2014)
• Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
  著者:: Alvarez, Enric, 等
  出版事項: (2014)
• A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
  著者:: Mahableshwarkar, Atul R, 等
  出版事項: (2015)